Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...
A Dutch court barred Merck from selling subcutaneous Keytruda in several European countries. Elsewhere, an Insmed executive ...
The better-than-expected results could make Epkinly the new “undisputed” treatment standard in newly diagnosed DLBCL, ...
The deal carries a $1 billion upfront payment and tasks the two companies to develop long-acting antibody drugs that go after ...
The Nobel laureates “laid the foundation” for a new field of brain research, the award committee wrote. Elsewhere, Roche and ...
Medical meetings often feature important clinical trial results, making them barometers of biotech and pharma companies’ research progress. Here’s a list of conferences to watch for in 2027.
The latest installment in BioPharma Dive’s data visualization series features a closer look at Kodiak’s stock performance and ...
The pharma giant cut its partnership after a cancer drug disappointed in testing. Elsewhere, Teva and Samsung Bioepis expanded a partnership and space biotech Varda brought in $251 million.
The company’s next-generation shot surpassed Wall Street’s expectations by matching the effectiveness of vaccines from Pfizer ...
The acquisition of Texas-based IntraBio adds to a growing rare disease business for Shionogi by handing the company a ...
The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...
The fundraise is the firm’s largest to date, providing a lift for a European biotech industry that’s fallen further behind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results